Home › Liver Cancer (Hepatocellular Carcinoma) › NCT05128890

Evaluation of Resection Techniques for Pancreatic Tumors

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
* Patients 18 years old or older

Exclusion Criteria:

* Patients that have not undergone pancreatic resection surgeries
* Patients under 18 years of age

About the study

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.

The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

What is being tested

• Resection techniques for pancreatic and liver tumors (procedure)

Sponsor: Methodist Health System · Participants: 431 · Started: Apr 16, 2016

Contact the study team

• Colette N Ndjom, MS · Phone: 214-947-4681
• Jennifer Kirchner · Phone: 214-947-4459

Official record on ClinicalTrials.gov — NCT05128890

Locations in the U.S.

Conditions

• Liver Cancer (Hepatocellular Carcinoma)
• Pancreatic Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.